Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient -- Genentech, Inc.(NYSE: DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
Severe Adverse Event Reported in Raptiva Patient GENEVA, Switzerland, October 2/PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc.has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient...
PDL taps Biogen Idec exec to oversee spinoff San Francisco Business Times - by Ron Leuty Related News The hiring of a Biogen Idec executive to head PDL BioPharma Inc.is raising speculation that the East Coast biotech powerhouse will take control of PDL.
Faheem Hasnain was named...
PDL taps Biogen Idec exec to oversee spinoff San Francisco Business Times - by Ron Leuty Related News The hiring of a Biogen Idec executive to head PDL BioPharma Inc.is raising speculation that the East Coast biotech powerhouse will take control of PDL.
Faheem Hasnain was named...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient BUSINESS WIRE)--Genentech, Inc.(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient...
Severe Adverse Event Reported in Raptiva Patient terms of use| privacy | copyright | site map Severe Adverse Event Reported in Raptiva Patient.
Another Case of PML: This Time Raptiva is Implicated (BioWorld Today Via Acquire Media NewsEdge) Genentech Inc.has issued an alert to the health care community about a case of a rare life-threatening brain infection in an elderly patient treated with Raptiva, making it the third...
Another Case of PML: This Time Raptiva is Implicated Genentech Inc.has issued an alert to the health care community about a case of a rare life-threatening brain infection in an elderly patient treated with Raptiva, making it the third therapy to be linked to the disease.
The viral...
Another Case of PML: This Time Raptiva is Implicated Genentech Inc.has issued an alert to the health care community about a case of a rare life-threatening brain infection in an elderly patient treated with Raptiva, making it the third therapy to be linked to the disease.
The viral...
Genentech Warns of Nerve Disease Cases Associated With Raptiva A 62-year-old man taking Genentechs Raptiva for psoriasis developed progressive Genentech Warns of Nerve Disease Cases Associated With Raptiva.
STOCKS NEWS EUROPE-Thin macro, corporate diaries on Monday 0830 EZ Sentix Index Sept 1400 US Employ Index Sept ---- JP BOJ meeting No major European companies due to report.No major U.S.
companies due to report.
Reuters Messaging rm://blaise.robinson.reuters.com@reuters.net 15:36GMT 03Oct2008...
STOCKS NEWS EUROPE-FTSE Small Cap index ends up 0.2 pct Share Price Search Search for Stock Code (eg.VOD) or Company Name: LSE.co.uk HomeShare PricesShare ChatFinance NewsStock Market NewsMacroeconomic NewsUK Money NewsPolitics NewsInternet NewsPersonal FinanceMembers Latest Share Chat 3-OCT...
STOCKS NEWS EUROPE-Stocks rise 2.9 pct on bailout hopes Share Price Search Search for Stock Code (eg.VOD) or Company Name: LSE.co.uk HomeShare PricesShare ChatFinance NewsStock Market NewsMacroeconomic NewsUK Money NewsPolitics NewsInternet NewsPersonal FinanceMembers Latest Share Chat 3-OCT...
STOCKS NEWS EUROPE-Thin macro, c 0830 EZ Sentix Index Sept 1400 US Employ Index Sept ---- JP BOJ meeting No major European companies due to report.No major U.S.
companies due to report.
Reuters Messaging rm://blaise.robinson.reuters.com@reuters.net 15:36GMT 03Oct2008...
STOCKS NEWS EUROPE-Stocks rise 2 Share Price Search Search for Stock Code (eg.VOD) or Company Name: LSE.co.uk HomeShare PricesShare ChatFinance NewsStock Market NewsMacroeconomic NewsUK Money NewsPolitics NewsInternet NewsPersonal FinanceMembers Latest Share Chat 3-OCT...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc.(NYSE:DNA - News) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc.(NYSE:DNA - News) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient Business Editors/Health/Medical Writers SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--October 2, 2008--Genentech, Inc.(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient -Genentech, Inc.(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient SOUTH SAN FRANCISCO, Calif.- (Business Wire) Genentech, Inc.
(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient SOUTH SAN FRANCISCO, Calif.Genentech, Inc.
(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient Genentech, Inc.(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc.(NYSE: DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient - Genentech, Inc.(NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
UPDATE 1-Genentech: Raptiva patient develops brain disorder LOS ANGELES, Oct 2 (Reuters) - Genentech Inc on Thursday warned doctors that a patient being treated with its psoriasis drug Raptiva has developed a rare brain infection known as progressive multifocal leukoencephalopathy, or PML.
